Life Sciences Seminar: New strategies for Antibiotic Dosing in the Age of Multidrug-Resistance
Life Sciences Seminar
New strategies for Antibiotic Dosing in the Age of Multidrug-Resistance
Zackary Bulman, PharmD ’11
Assistant Professor
College of Pharmacy, Department of Pharmacy Practice
University of Illinois at Chicago
RIT Biotechnology BS Alum
Abstract:
This presentation will identify new approaches to combat clinically relevant multidrug-resistant bacteria such as Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii. Different approaches to dosing antibiotics, use of unique antibiotic combinations, and consideration of molecular mechanisms of resistance in antibiotic selection will be discussed. Dr. Bulman’s team aims to devise novel therapeutic approaches that are capable of successfully treating infectious diseases while also suppressing the amplification of new resistance mechanisms.
Speaker Bio:
Dr. Bulman graduated from RIT with a BS in Biotechnology in 2011 (2008-2011). He then received his doctor of pharmacy degree from the University at Buffalo in 2015. Following a two year post-doc, he became an Assistant Professor at the University of Illinois Chicago College of Pharmacy (2017-present) where he leads a research team that aims to develop new treatment strategies for extensively resistant bacteria. Dr. Bulman has obtained over $4 million in research grants from the NIH and other competitive funding sources. He was recently awarded an NIH/NIAID R01 as PI to study precision medicine approaches for resistant bacteria. His 5-year R01 is among the largest such awards received by a Pharm.D. He has published >40 peer-reviewed publications and >50 abstracts. His expertise in the field of antimicrobial resistance and antibiotic selection is reflected in numerous honors and awards, including recognition as a Fellow of the International Society of Antimicrobial Chemotherapy and as an Editor of mSystems, an American Society for Microbiology journal. He has recently received the 2022 UIC Rising Star Award, 2023 New Investigator Award from the American College of Clinical Pharmacy and the 2023 Early Career Investigator Award from the Society of Infectious Diseases Pharmacists.
Intended Audience:
Beginners, undergraduates, graduates, experts. Those with interest in the topic.
To request an interpreter, please visit myaccess.rit.edu
Event Snapshot
When and Where
Who
Open to the Public
Interpreter Requested?
No